The Effectiveness of Dual Therapy (Lopinavir/Ritonavir + LamivudinE) in Treatment-Experienced HIV Infected Patients in the Russian Federation

NCT02581202 · clinicaltrials.gov ↗

COMPLETED

Status

216

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV-1 Infection

Interventions

DRUG: lopinavir/ritonavir
DRUG: lamivudine

Sponsor

AbbVie